Global EditionASIA 中文雙語Fran?ais
    China
    Home / China / Health

    China approves new self-developed cancer drug

    Xinhua | Updated: 2020-06-06 20:12
    Share
    Share - WeChat

    BEIJING - China has granted market access to a self-developed cancer drug, according to the National Medical Products Administration.

    The drug, known as Brukinsa (zanubrutinib) in capsule form, was developed by the biotechnology company BeiGene. It is for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy, and also for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

    The drug was approved through a priority review procedure and its marketing authorization holder should continue with the confirmatory clinical trials, according to the administration.

    The approval of the drug will provide an important treatment option for Chinese patients with lymphoma.

    Wu Xiaobin, president of BeiGene said the development of the drug has taken more than eight years and around 25 clinical trials have been carried out in more than 20 countries, involving more than 500 international clinical experts. More than 1,700 patients have joined the clinical trials globally.

    The approval of the drug also underlines China's progress in developing innovative drugs, Wu said.

    In November last year, the drug received approval from the US Food and Drug Administration as a treatment for MCL in adult patients who have received at least one prior therapy.

    Wang Zhiwei, vice president of BeiGene said the company's production line in the city of Suzhou, East China's Jiangsu province has an annual output of 100 million capsules, which can ensure the demand of the domestic market as well as the international market.

    Lymphoma is a type of blood cancer which has seen increasing incidence both in China and the world.

    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
     
    免费无码又爽又刺激网站 | 日韩爆乳一区二区无码| 无码中文字幕av免费放dvd| 无码人妻精品一区二区三区99仓本| 日韩AV无码中文无码不卡电影| 人妻无码一区二区三区AV| 久久无码AV中文出轨人妻| 亚洲永久无码3D动漫一区| www.中文字幕| 亚洲精品无码久久久| 久久精品aⅴ无码中文字字幕重口| 一区二区三区在线观看中文字幕| 中文字幕在线无码一区| 本道天堂成在人线av无码免费| 日韩精品无码一区二区三区AV| 人妻丰满av无码中文字幕| 亚洲精品无码专区在线播放| 日韩AV无码中文无码不卡电影| 日日麻批免费40分钟无码| 欧美精品丝袜久久久中文字幕| 国产成人亚洲综合无码| 免费人妻无码不卡中文字幕系 | 久久精品无码一区二区WWW | 自慰无码一区二区三区| 无码精品A∨在线观看十八禁| 亚洲美日韩Av中文字幕无码久久久妻妇| 日韩乱码人妻无码中文字幕| 中文字幕无码高清晰| 亚洲一级Av无码毛片久久精品| av无码专区| 成人午夜福利免费无码视频| 国产成人无码18禁午夜福利p| 无码欧精品亚洲日韩一区| 亚洲av无码国产精品色午夜字幕 | 亚洲欧美日韩另类中文字幕组| 欧美日韩国产中文字幕| 中文字幕精品亚洲无线码二区| 精品久久久久久无码免费| 国产午夜无码片免费| Aⅴ精品无码无卡在线观看| 东京热加勒比无码少妇|